检索结果 - Shingo Dan
- Showing 1 - 13 results of 13
-
1
-
2
-
3
-
4
-
5
AMF-26, a Novel Inhibitor of the Golgi System, Targeting ADP-ribosylation Factor 1 (Arf1) with Potential for Cancer Therapy 由 Yoshimi Ohashi, Hiroshi Iijima, Noriyuki Yamaotsu, Kanami Yamazaki, Shigeo Sato, Mutsumi Okamura, Kenji Sugimoto, Shingo Dan, Shuichi Hirono, Takao Yamori
出版 2011Artigo -
6
-
7
Correlating Phosphatidylinositol 3-Kinase Inhibitor Efficacy with Signaling Pathway Status: <i>In silico</i> and Biological Evaluations 由 Shingo Dan, Mutsumi Okamura, Mariko Seki, Kanami Yamazaki, Hironobu Sugita, Michiyo Okui, Yumiko Mukai, Hiroyuki Nishimura, Reimi Asaka, Kimie Nomura, Yuichi Ishikawa, Takao Yamori
出版 2010Artigo -
8
Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer 由 Mitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, Takeru Wakatsuki, Yuki Horiike, Satoshi Matsusaka, Shingo Dan, Eiji Shinozaki, Hiroyuki Seimiya, Nobuyuki Mizunuma, Kensei Yamaguchi, Toshiharu Yamaguchi
出版 2016Artigo -
9
TUFT1 interacts with RABGAP1 and regulates mTORC1 signaling 由 Natsumi Kawasaki, Kazunobu Isogaya, Shingo Dan, Takao Yamori, Hiroshi Takano, Ryoji Yao, Yasuyuki Morishita, Luna Taguchi, Masato Morikawa, Carl‐Henrik Heldin, Tetsuo Noda, Shogo Ehata, Kohei Miyazono, Daizo Koinuma
出版 2018Artigo -
10
High-throughput screening in colorectal cancer tissue-originated spheroids 由 Jumpei Kondo, Tomoya Ekawa, Hiroko Endo, Kanami Yamazaki, Norio Tanaka, Yoji Kukita, Hiroaki Okuyama, Jiro Okami, Fumio Imamura, Masayuki Ohue, Kikuya Kato, Taisei Nomura, Arihiro Kohara, Seiichi Mori, Shingo Dan, Masahiro Inoue
出版 2018Artigo -
11
Synthetic biology based construction of biological activity-related library of fungal decalin-containing diterpenoid pyrones 由 Kento Tsukada, Shono Shinki, Akiho Kaneko, Kazuma Murakami, Kazuhiro Irie, Masatoshi Murai, Hideto Miyoshi, Shingo Dan, Kumi Kawaji, Hironori Hayashi, Eiichi Kodama, Aki Hori, Emil Salim, Takayuki Kuraishi, Naoya Hirata, Yasunari Kanda, Teigo Asai
出版 2020Artigo -
12
A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation 由 Xin Peng, Xin Huang, Talal Ben Lulu, Wenqing Jia, Shaolu Zhang, Limor Cohen, Shengfan Huang, Jindian Fan, Xi Chen, Shanshan Liu, Yongzhe Wang, Kailin Wang, Sho Isoyama, Shingo Dan, Feng Wang, Zhe Zhang, Moshe Elkabets, Dexin Kong
出版 2024Artigo -
13
SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis 由 Akane Ogawa, Keiichi Izumikawa, Sota Tate, Sho Isoyama, Mori Masaru, Kohei Fujiwara, Soyoka Watanabe, Takayuki Ohga, Ukhyun Jo, Daiki Taniyama, Shojiro Kitajima, Soichiro Tanaka, Hiroshi Onji, Shun‐Ichiro Kageyama, Gaku Yamamoto, Hitoshi Saito, Tomoko Morita, Masayasu Okada, Manabu Natsumeda, Masami Nagahama, Junya Kobayashi, Akihiro Ohashi, Hiroyuki Sasanuma, Shigeki Higashiyama, Shingo Dan, Yves Pommier, Junko Murai
出版 2025Artigo
相关主题
Biology
Cancer research
Cell biology
Biochemistry
Cancer
Genetics
Signal transduction
Apoptosis
Chemistry
PI3K/AKT/mTOR pathway
Gene
In vivo
Internal medicine
Medicine
Cell culture
Colorectal cancer
Immunology
Kinase
Receptor
Biotechnology
Cancer cell
Cell
Computational biology
Enzyme
GTPase
Immune system
Intracellular
MAPK/ERK pathway
Molecular biology
Pharmacology